Mandy Conver
About Mandy Conver
Mandy Conver's Role at QIAGEN
Mandy Conver serves as the Vice President of Commercial Operations with a focus on commercial leadership and building technical teams for cell and gene therapy clients. She played a crucial role in the successful launch of QIAGEN's QIAcuity Digital PCR portfolio in North America. Her responsibilities included overseeing market strategy and commercial activities, which involved creating a specialized commercial team and implementing customized training for a large matrix sales organization. Additionally, Mandy has been instrumental in negotiating strategic alliances and influencing the evolution of QIAGEN's portfolio.
Mandy Conver's Experience in Biotechnology and BioPharma
Mandy Conver has over two decades of diverse experience in the biotechnology and BioPharma industries. Her career spans significant roles focused on commercial leadership and team building, especially in the context of cell and gene therapy clients. Her expertise includes strategy formulation, team development, process management, and commercial analytics. She has a profound understanding of the testing required for advanced therapies at all stages of development and manufacturing.
Mandy Conver's Contributions to Bio-Rad Laboratories
At Bio-Rad Laboratories, Mandy Conver contributed to the company's strategic focus in the BioPharma market. She was responsible for creating a BioPharma-focused commercial team that led Bio-Rad's early ventures into the cell and gene therapy space. She was pivotal in building the organization's knowledge around analytical method development and GMP compliance and played a key role in enhancing regulatory engagement for advanced therapies.
Commercial and Market Strategy Expertise of Mandy Conver
Mandy Conver has extensive expertise in commercial and market strategy within the biotechnology and BioPharma industries. At QIAGEN, she oversaw the market strategy and commercial activities which included creating a specialized commercial team and customized training programs for a large matrix sales organization. Her adept skills in negotiating strategic alliances and shaping portfolio evolution have significantly benefitted the companies she has worked with.